On August 29, 2024, Shitij Kapur, President of King’s College London (KCL) of the United Kingdom, led a delegation to visit Peking University. During the meeting, the two universities announced that the fourth round of project application of “PKUHSC-KCL Joint Institute for Medical Research” would be issued in September 2024.

　　Qiao Jie, PKU Executive Vice President, PKUHSC President, and Member of the Chinese Academy of Engineering, expressed during the meeting that the two sides had a profound foundation in scientific research cooperation and talent training. She hoped that the two sides would continue to work together to promote medical development in the future.

　　President Kapur said that there had been a long history of cooperation between KCL and PKU and the cooperation in medicine had yielded fruitful achievements, especially the research fields of tumor, mental health, and cardiovascular diseases, which had made important contributions to the promotion of the development of global health cause. Kapur also emphasized that KCL cherished its partnership with PKU and looked forward to promoting scientific research and technological innovation in the future and working together to cultivate more innovative talents with international competitiveness.

　　After the meeting, the two universities signed a new medical undergraduate exchange agreement, which strengthens the two sides’ cooperation in medical education and talent training.

　　Before the meeting, the two sides held an academic exchange seminar. Lu Lin, President of PKU Sixth Hospital and Member of the Chinese Academy of Sciences, and Professor Wang Guiqiang from PKUHSC Department of Infectious Disease held in-depth discussions with visiting experts on innovative models of medical education, scientific research cooperation and talent training in the fields of neuroscience, mental health and infectious diseases.

　　Written by: Lang Lang

　　Edited by: Liu Xin

　　Source: Office of International Cooperation